Download PDF
Synlett 2018; 29(09): 1176-1180
DOI: 10.1055/s-0037-1609347
letter
© Georg Thieme Verlag Stuttgart · New York

Facile Access to 1,5-Benzodiazepines via Amine-Promoted (4+3) Annulations of δ-Acetoxy Allenoates with o-Diaminobenzenes under Mild Conditions

Yi-Fan Wang
a   Key Laboratory for Advanced Materials and Institute of Fine Chemicals, East China University of Science and Technology, 130 Meilong Road, Shanghai, 200237, P. R. of China   Email: tongxf@ecust.edu.cn
,
Cheng-Yu He
b   Key Laboratory of Synthetic Chemistry of Natural Substances, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 345 Lingling Road, Shanghai 200032, P. R. of China   Email: tianping@sioc.ac.cn
,
Longlei Hou
a   Key Laboratory for Advanced Materials and Institute of Fine Chemicals, East China University of Science and Technology, 130 Meilong Road, Shanghai, 200237, P. R. of China   Email: tongxf@ecust.edu.cn
,
Ping Tian  *
b   Key Laboratory of Synthetic Chemistry of Natural Substances, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 345 Lingling Road, Shanghai 200032, P. R. of China   Email: tianping@sioc.ac.cn
c   Innovation Research Institute of Traditional Chinese Medicine (IRI), Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, P. R. of China   Email: tianping@shutcm.edu.cn
,
Guo-Qiang Lin
b   Key Laboratory of Synthetic Chemistry of Natural Substances, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 345 Lingling Road, Shanghai 200032, P. R. of China   Email: tianping@sioc.ac.cn
c   Innovation Research Institute of Traditional Chinese Medicine (IRI), Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, P. R. of China   Email: tianping@shutcm.edu.cn
,
Xiaofeng Tong*
a   Key Laboratory for Advanced Materials and Institute of Fine Chemicals, East China University of Science and Technology, 130 Meilong Road, Shanghai, 200237, P. R. of China   Email: tongxf@ecust.edu.cn
› Author AffiliationsFinancial support was generously provided by the 973 Program (2015CB856600), NSFC (21472042, 21772016, 21572251, 21572253), and the Collaborative Innovation Center of Chemical Science and Engineering (Tianjin).
Further Information

Publication History

Received: 20 January 2018

Accepted after revision: 20 February 2018

Publication Date:
23 March 2018 (online)

    Permissions and Reprints All articles of this category


Abstract

An amine-promoted (4+3) annulation of δ-acetoxy allenoate with o-diaminobenzene is reported, providing a facile access to 1,5-benzodiazepine. This method features wide reaction scope, mild conditions, and readily available starting materials. The cascade reaction involves aza-Michael addition of o-diaminobenzene to allenoate, elimination of acetate group, and subsequent 1,6-aza-Michael addition.

Key words

1,5-benzodiazepine - annulation - allenoate - diamino­benzene - catalyst-free

Supporting Information

    Supporting information for this article is available online at https://doi.org/10.1055/s-0037-1609347.
  • Supporting Information
 

  • References and Notes

    • 1a Randall O. Kappel B. In Benzodiazepines . Garattini S. Mussini E. Randall LO. Raven Press; New York: 1973: 27
      Google Scholar
    • 1b Schütz H. In Benzodiazepines . Springer; Heidelberg: 1982
      Google Scholar
  • 2 Knabe J. Büch HP. Bender S. Arch. Pharm. 1995; 328: 59
    CrossrefPubMed
  • 3 Atwal KS. Bergey JL. Hedberg A. Moreland S. J. Med. Chem. 1987; 30: 635
    CrossrefPubMed
  • 4 Di Braccio M. Grossi G. Roma G. Vargiu L. Mura M. Marongiu ME. Eur. J. Med. Chem. 2001; 36: 935
    CrossrefPubMed
    • 5a Aversa MC. Ferlazzo A. Giannetto P. Kohnke FH. Synthesis 1986; 230
      Article in Thieme Connect
    • 5b Chimirri A. Grasso S. Ottana R. Romeo G. Zappala M. J. Heterocycl. Chem. 1990; 27: 371
      Crossref
    • 6a Evans BE. Rittle KE. Bock MG. DiPardo RM. Freidinger RM. Whitter WL. Lundell GF. Veber DF. Anderson PS. J. Med. Chem. 1988; 31: 2235
      CrossrefPubMed
    • 6b Patchett AA. Nargund RP. Annu. Rep. Med. Chem. 2000; 35: 289
    • 6c Triggle DJ. Cell. Mol. Neurobiol. 2003; 23: 293
      CrossrefPubMed
    • 6d Poupaert J. Carato P. Colacino E. Curr. Med. Chem. 2005; 12: 877
      CrossrefPubMed

      For the selected examples, see:
    • 7a Nardi M. Cozza A. Maiuolo L. Oliverio M. Procopio A. Tetrahedron Lett. 2011; 52: 4827
      Crossref
    • 7b Aversa MC. Ferlazzo A. Gionnetto P. Kohnke FH. Synthesis 1986; 230
      Article in Thieme Connect
    • 7c Zhang XY. Xu JX. Jin S. Chin. J. Chem. 1999; 17: 404
    • 7d Yadav JS. Reddy BV. S. Praveenkumar S. Nagaiah K. Lingaiah N. Saiprasad PS. Synthesis 2004; 901
      Article in Thieme Connect
    • 7e Jamatia R. Gupta A. Dam B. Sahab M. Pal AK. Green Chem. 2017; 19: 1576
      Crossref
    • 7f Gharib A. Jahangir M. Scheeren JW. Synth. Commun. 2013; 43: 309
      Crossref
    • 7g Vaddula BR. Varma RS. Leazer J. Tetrahedron Lett. 2013; 54: 1538
      Crossref
    • 7h Ding Z.-Y. Chen F. Qin J. He Y.-M. Fan Q.-H. Angew. Chem. Int. Ed. 2012; 51: 5706
      CrossrefPubMed
    • 8a Sarkar S. Deka JK. R. Hazra JP. Khan AT. Synlett 2013; 24: 2601
      Article in Thieme Connect
    • 8b Sotoca E. Allais C. Constantieux T. Rodriguez J. Org. Biomol. Chem. 2009; 7: 1911
      CrossrefPubMed
    • 8c Lal M. Basha RS. Sarkar S. Khan AT. Tetrahedron Lett. 2013; 54: 4264
      Crossref
    • 9a Hu J. Dong W. Wu X.-Y. Tong X. Org. Lett. 2012; 14: 5530
      CrossrefPubMed
    • 9b Wang D. Tong X. Org. Lett. 2017; 19: 6392
      CrossrefPubMed
    • 9c Zhou W. Ni C. Chen J. Wang D. Tong X. Org. Lett. 2017; 19: 1890
      CrossrefPubMed
    • 9d Ni C. Chen J. Zhang Y. Hou Y. Wang D. Tong X. Zhu S.-F. Zhou Q.-L. Org. Lett. 2017; 19: 3668
      CrossrefPubMed
    • 9e Zhang Y. Tong X. Org. Lett. 2017; 19: 5462
      CrossrefPubMed
    • 9f Gu Y. Li F. Hu P. Liao D. Tong X. Org. Lett. 2015; 17: 1106
      CrossrefPubMed
  • 10 CCDC 1816325 contains the supplementary crystallographic data for 3ga. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/getstructures.
  • 11 Acetoxy Allenoates 1 and o-Diaminobenzenes 2 To a 10 mL vial were added o-diaminobenzene 2 (0.2 mmol, 1.0 equiv), DIPEA (0.24 mmol, 1.2 equiv), and toluene (2 mL), followed by the slow addition of a solution of δ-acetoxy allenoate 1 (0.24 mmol,1.2 equiv) in toluene (2 mL). The solution was stirred for 12 h at room temperature. The reaction mixture was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography using petroleum ether and ethyl acetate (30:1 to 15:1 v/v) as the eluent to give the corresponding annulations product 3. Ethyl (Z)-2-{4-(4-Isopropylphenyl)-1,3,4,5-tetrahydro-2H-benzo[b][1,4]diazepin-2-ylidene}acetate (3da) Yellow solid, 86% yield; mp 70–72 °C. 1H NMR (400 MHz, CDCl3): δ = 10.26 (s, 1 H), 7.26 (d, J = 8.2 Hz, 2 H), 7.20 (d, J = 8.2 Hz, 2 H), 6.99–6.93 (m, 2 H), 6.92–6.85 (m, 1 H), 6.76–6.72 (m, 1 H), 4.79 (dd, J = 9.6, 3.8 Hz, 1 H), 4.64 (s, 1 H), 4.23–4.06 (m, 2 H), 3.66 (br s, 1 H),2.90 (hept, J = 6.9 Hz, 1 H), 2.72 (dd, J = 13.8, 9.6 Hz, 1 H), 2.49 (ddd, J = 13.8, 3.8, 1.3 Hz, 1 H), 1.34–1.17 (m, 9 H). 13C NMR (100 MHz, CDCl3): δ = 170.28, 158.84, 148.67, 142.39, 137.83, 129.65, 126.80, 125.98, 124.91, 122.48, 121.35, 120.70, 83.95, 64.84, 58.79, 40.39, 33.76, 23.94, 23.91, 14.53. IR (KBr): 3853, 3336, 2960, 2929, 2870, 1734, 1654, 1616, 1560, 1540, 1507, 1480, 1437, 1364, 1286, 1266, 1246, 1157, 1117, 1095, 1051, 829 cm–1. HRMS (ESI): m/z calcd for C22H27N2O2 +: 351.2067; found: 351.2067 [M + H]+. Ethyl (Z)-2-{4-(4-Cyanophenyl)-1,3,4,5-tetrahydro-2H-benzo[b]­[1,4]diazepin-2-ylidene}acetate (3ha) Yellow solid, 72% yield; mp 60–62 °C. 1H NMR (400 MHz, CDCl3): δ = 10.16 (s, 1 H), 7.66–7.60 (m, 2 H), 7.55–7.50 (m, 2 H), 7.03–6.92 (m, 3 H), 6.83–6.79 (m, 1 H), 5.00–4.92 (m, 1 H), 4.43 (s, 1 H), 4.21–4.04 (m, 2 H), 3.73 (s, 1 H), 2.73 (dd, J = 13.8, 4.7 Hz, 1 H), 2.49 (dd, J = 13.9, 7.0 Hz, 1 H), 1.26 (t, J = 7.1 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 169.98, 157.03, 149.30, 137.66, 132.43, 130.48, 127.12, 125.09, 122.49, 122.38, 120.97, 118.63, 111.61, 85.04, 64.57, 58.93, 39.37, 14.44. IR (neat): 3629, 3567, 3343, 3057, 2980, 2931, 2228, 1734, 1653, 1616, 1559, 1541, 1501, 1437, 1405, 1364, 1284, 1267, 1233, 1159, 1118, 1095, 1048, 833 cm–1. HRMS (ESI): m/z calcd for C20H20N3O2 +: 334.1550; found: 334.1550 [M + H]+. Ethyl (Z)-2-{4-Methyl-1,3,4,5-tetrahydro-2H-benzo[b][1,4]dia­zepin-2-ylidene}acetate (3pa) Yellow liquid, 82% yield. 1H NMR (400 MHz, CDCl3): δ = 10.13 (s, 1 H), 6.91–6.75 (m, 3 H), 6.71–6.64 (m, 1 H), 4.61 (s, 1 H), 4.08 (q, J = 7.1 Hz, 2 H), 3.88–3.76 (m, 1 H), 3.17 (br s, 1 H), 2.40 (dd, J = 13.8, 4.4 Hz, 1 H), 2.15 (dd, J = 13.8, 7.0 Hz, 1 H), 1.26–1.17 (m, 6 H).13C NMR (100 MHz, CDCl3): δ = 170.11, 159.16, 137.87, 130.34, 124.67, 122.27, 121.67, 120.90, 84.25, 58.79, 55.83, 39.31, 23.40, 14.54. IR (neat): 3347, 2973, 2927, 1648, 1616, 1588, 1498, 1447, 1364, 1307, 1274, 1232, 1159, 1115, 1095, 1044, 916, 784 cm–1. HRMS (ESI): m/z calcd for C14H19N2O2 +: 247.1441; found: 247.1440 [M + H]+. Ethyl (Z)-2-{4-Benzyl-1,3,4,5-tetrahydro-2H-benzo[b][1,4]dia­zepin-2-ylidene}acetate (3qa) Yellow solid, 85% yield; mp 106–108 °C. 1H NMR (400 MHz, CDCl3): δ = 10.13 (s, 1 H),7.31–7.12 (m, 5 H), 6.89–6.75 (m, 3 H), 6.63–6.56 (m, 1 H), 4.64 (s, 1 H),4.16–4.00 (m, 2 H),3.94–3.82 (m, 1 H), 3.23 (br s, 1 H), 2.82–2.67 (m, 2 H), 2.42 (dd, J = 13.7, 4.7 Hz, 1 H), 2.23 (dd, J = 13.8, 7.2 Hz, 1 H), 1.21 (t, J = 7.1 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 170.08, 158.92, 137.89, 137.57, 130.94, 129.27, 128.74, 126.70, 124.69, 122.15, 121.95, 121.33, 84.32, 62.01, 58.80, 43.31, 37.26, 14.52. IR (neat): 3386, 1618, 1588, 1505, 1404, 1365, 1332, 1285, 1262, 1225, 1158, 1123, 1095, 1065, 1039, 1004, 790 cm–1. HRMS (ESI): m/z calcd for C20H23N2O2 +: 323.1754; found: 323.1757 [M + H]+. Ethyl (Z)-2-{1,3,4,5-Tetrahydro-2H-benzo[b][1,4]diazepin-2-ylidene}acetate (3ra) Yellow solid, 45% yield; mp 56–58 °C. 1H NMR (400 MHz, CDCl3): δ = 10.22 (s, 1 H), 6.88–6.79 (m, 2 H), 6.76–6.70 (m, 1 H), 6.67–6.59 (m, 1 H), 4.61 (s, 1 H), 4.08 (q, J = 7.1 Hz, 2 H), 3.60–3.52 (m, 2 H), 3.13 (br s, 1 H), 2.49–2.41 (m, 2 H), 1.21 (t, J = 7.1 Hz, 3 H).13C NMR (100 MHz, CDCl3): δ = 170.34, 160.98, 138.16, 128.87, 124.60, 122.64, 120.60, 119.79, 83.32, 58.81, 48.70, 33.76, 14.55. IR (neat): 3386, 1618, 1588, 1505, 1404, 1365, 1332, 1285, 1262, 1225, 1158, 1123, 1095, 1065, 1039, 1004, 790 cm–1. HRMS (ESI): m/z calcd for C13H17N2O2 +: 233.1285; found: 233.1284 [M + H]+. Ethyl (Z)-2-{7,8-Dimethyl-4-phenyl-1,3,4,5-tetrahydro-2H-benzo[b][1,4]diazepin-2-ylidene}acetate (3ab) Yellow solid, 70% yield; mp 100–102 °C. 1H NMR (400 MHz, CDCl3): δ = 10.18 (s, 1 H), 7.41–7.22 (m, 5 H), 6.76 (s, 1 H), 6.55 (s, 1 H), 4.80 (dd, J = 9.2, 4.0 Hz, 1 H), 4.58 (s, 1 H), 4.23–4.05 (m, 2 H), 3.56 (br s, 1 H), 2.67 (dd, J = 13.7, 9.2 Hz, 1 H), 2.50 (ddd, J = 13.7, 4.0, 1.1 Hz, 1 H), 2.17 (s, 6 H), 1.27 (t, J = 7.1 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 170.29, 158.92, 145.05, 135.43, 133.22, 129.69, 128.73, 127.83, 127.41, 126.05, 123.53, 121.90, 83.54, 65.16, 58.73, 40.37, 19.10, 18.74, 14.55. IR (KBr): 3376, 3276, 3064, 2973, 2906, 2888, 2859, 1654, 1609, 1513, 1482, 1451, 1428, 1365, 1310, 1281, 1242, 1199, 1160, 1129, 1094, 1048, 988, 950, 897 cm–1. HRMS (ESI): m/z calcd for C21H25N2O2 +: 337.1911; found: 337.1910 [M + H]+. Ethyl (Z)-2-{7,8-Dibromo-4-phenyl-1,3,4,5-tetrahydro-2H-benzo[b][1,4]diazepin-2-ylidene}acetate (3ae) Yellow solid, 34% yield; mp 60–62 °C. 1H NMR (400 MHz, CDCl3): δ = 10.17 (s, 1 H), 7.35–7.16 (m, 5 H), 7.13 (s, 1 H), 6.94 (s, 1 H), 4.72 (dd, J = 9.1, 3.6 Hz, 1 H), 4.57 (s, 1 H), 4.16–3.99 (m, 2 H), 3.69 (br s, 1 H), 2.62 (dd, J = 14.0, 9.1 Hz, 1 H), 2.48 (dd, J = 14.0, 3.7 Hz, 1 H), 1.20 (t, J = 7.1 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 170.23, 157.97, 143.54, 137.84, 131.84, 130.32, 128.03, 125.10, 122.55, 122.08, 121.74, 121.01, 84.72, 64.57, 58.98, 39.93, 14.61. IR (neat): 3420, 3132, 1717, 1653, 1617, 1559, 1540, 1507, 1490, 1457, 1404, 1300, 1239, 1160, 1066, 1010, 700 cm–1. HRMS (ESI): m/z calcd for C19H19 Br2N2O2 +: 464.9808; found: 464.9806 [M + H]+. Ethyl (Z)-2-{4-Phenyl-1,3,4,5-tetrahydro-2H-naphtho[2,3-b][1,4]diazepin-2-ylidene}acetate (3af) Yellow solid, 51% yield; mp 65–67 °C. 1H NMR (400 MHz, CDCl3): δ = 10.43 (s, 1 H), 7.71–7.59 (m, 2 H), 7.45–7.23 (m, 8 H), 7.16 (s, 1 H), 4.85 (dd, J = 9.1, 4.6 Hz, 1 H), 4.67 (s, 1 H), 4.25–4.11 (m, 2 H), 3.96 (s, 1 H), 2.70 (dd, J = 13.8, 9.1 Hz, 1 H), 2.60 (dd, J = 13.8, 4.6 Hz, 1 H), 1.30 (t, J = 7.1 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 170.24, 158.02, 144.63, 137.89, 132.05, 131.81, 129.99, 128.83, 128.00, 126.73, 126.15, 125.77, 125.25, 124.32, 119.10, 116.58, 85.17, 64.80, 59.00, 39.54, 14.54. IR (KBr): 3629, 3619, 3600, 3587, 3567, 3546, 3528, 3503, 3355, 3056, 2977, 2926, 1734, 1717, 1684, 1654, 1616, 1576, 1559, 1541, 1522, 1507, 1490, 1474, 1457, 1437, 1364, 1286, 1248, 1185, 1156, 1096, 1047, 872, 788 cm–1. HRMS (ESI). m/z calcd for C23H23N2O2 +: 359.1754; found: 359.1753 [M + H]+.
    • 12a Li F. Chen J. Hou Y. Li Y. Wu X.-Y. Tong X. Org. Lett. 2015; 17: 5376
      CrossrefPubMed
    • 12b Ni C. Yuan Y. Zhang Y. Chen J. Wang D. Tong X. Org. Biomol. Chem. 2017; 15: 4807
      CrossrefPubMed
    • 12c Sabbasani VR. Mamidipalli P. Lu H. Xia Y. Lee D. Org. Lett. 2013; 15: 1552
      CrossrefPubMed
    • 12d Zhao Y. Wang Y. Gu Z. Wang Z. Org. Biomol. Chem. 2017; 15: 4014
      CrossrefPubMed